PDB: 1008 resultsInfo pagesStatus searchChemie searchBIRD

---

6NNX	Crystal Structure of the All-Trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121M Mutant of Human Cellular Retinoic Acid Binding Protein II in the Dark at 1.87 Angstrom Resolution Descriptor: Cellular retinoic acid-binding protein 2, RETINAL Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2019-01-15 Release date: 2019-01-30 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.87 Å) Cite: Crystal Structure of the All-Trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121M Mutant of Human Cellular Retionic Acid Binding Protein II in the Dark at 1.87 Angstrom Resolution To Be Published
6NNY	Crystal Structure of the All-Trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39E:R59Y:L121E Mutant of Human Cellular Retinoic Acid Binding Protein II in the Dark at 1.67 Angstrom Resolution Descriptor: Cellular retinoic acid-binding protein 2, RETINAL Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2019-01-15 Release date: 2019-01-30 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.668 Å) Cite: Crystal Structure of the All-Trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39E:R59Y:L121E Mutant of Human Cellular Retinoic Acid Binding Protein II in the Dark at 1.68 Angstrom Resolution To Be Published
6E6M	Crystal structure of human cellular retinol-binding protein 1 in complex with cannabidiorcin (CBDO) Descriptor: (1'R,2'R)-4,5'-dimethyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol, Retinol-binding protein 1 Authors: Silvaroli, J.A, Horwitz, S, Banerjee, S, Kiser, P.D, Golczak, M. Deposit date: 2018-07-25 Release date: 2019-02-13 Last modified: 2024-03-13 Method: X-RAY DIFFRACTION (1.55 Å) Cite: Abnormal Cannabidiol Modulates Vitamin A Metabolism by Acting as a Competitive Inhibitor of CRBP1. Acs Chem.Biol., 14, 2019
6E5T	Crystal structure of human cellular retinol binding protein 1 in complex with abnormal-cannabidiorcin (Abn-CBDO) Descriptor: (1'R,2'R)-5',6-dimethyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,4-diol, Retinol-binding protein 1 Authors: Silvaroli, J.A, Horwitz, S, Banerjee, S, Kiser, P.D, Golczak, M. Deposit date: 2018-07-23 Release date: 2019-02-13 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.55 Å) Cite: Abnormal Cannabidiol Modulates Vitamin A Metabolism by Acting as a Competitive Inhibitor of CRBP1. Acs Chem.Biol., 14, 2019
6E5W	Crystal structure of human cellular retinol binding protein 3 in complex with abnormal-cannabidiol (abn-CBD) Descriptor: (1'R,2'R)-5'-methyl-6-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,4-diol, GLYCEROL, Retinol-binding protein 5 Authors: Silvaroli, J.A, Banerjee, S, Kiser, P.D, Golczak, M. Deposit date: 2018-07-23 Release date: 2019-02-13 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.5 Å) Cite: Abnormal Cannabidiol Modulates Vitamin A Metabolism by Acting as a Competitive Inhibitor of CRBP1. Acs Chem.Biol., 14, 2019
6E6K	Crystal structure of human cellular retinol-binding protein 4 in complex with abnormal-cannabidiol (abn-CBD) Descriptor: (1'R,2'R)-5'-methyl-6-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,4-diol, Retinoid-binding protein 7 Authors: Silvaroli, J.A, Banerjee, S, Kiser, P.D, Golczak, M. Deposit date: 2018-07-25 Release date: 2019-02-13 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.3 Å) Cite: Abnormal Cannabidiol Modulates Vitamin A Metabolism by Acting as a Competitive Inhibitor of CRBP1. Acs Chem.Biol., 14, 2019
6E5L	Crystal structure of human cellular retinol binding protein 1 in complex with abnormal-cannabidiol (abn-CBD) Descriptor: (1'R,2'R)-5'-methyl-6-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,4-diol, Retinol-binding protein 1 Authors: Silvaroli, J.A, Banerjee, S, Kiser, P.D, Golczak, M. Deposit date: 2018-07-20 Release date: 2019-02-13 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.17 Å) Cite: Abnormal Cannabidiol Modulates Vitamin A Metabolism by Acting as a Competitive Inhibitor of CRBP1. Acs Chem.Biol., 14, 2019
6QPD	Engineered beta-lactoglobulin: variant I56F Descriptor: Beta-lactoglobulin, GLYCEROL, SULFATE ION Authors: Loch, J.I, Kaczor, K, Leiwnski, K. Deposit date: 2019-02-13 Release date: 2019-02-27 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2 Å) Cite: Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
6QPE	Engineered beta-lactoglobulin: variant L58F Descriptor: ACETATE ION, Beta-lactoglobulin Authors: Loch, J.I, Kaczor, K, Leiwnski, K. Deposit date: 2019-02-13 Release date: 2019-02-27 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.2 Å) Cite: Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
6RWP	Engineered beta-lactoglobulin: variant L58F in complex with myristic acid Descriptor: Beta-lactoglobulin, MYRISTIC ACID, SULFATE ION Authors: Loch, J.I, Kaczor, K, Lewinski, K. Deposit date: 2019-06-05 Release date: 2019-06-19 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.1 Å) Cite: Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
6RWQ	Engineered beta-lactoglobulin: variant F105L in complex with myristic acid Descriptor: 1,2-ETHANEDIOL, Beta-lactoglobulin, MYRISTIC ACID Authors: Loch, J.I, Gotkowski, M, Lewinski, K. Deposit date: 2019-06-05 Release date: 2019-06-19 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.05 Å) Cite: Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
6RWR	Engineered beta-lactoglobulin: variant M107L in complex with myristic acid Descriptor: Beta-lactoglobulin, MYRISTIC ACID Authors: Loch, J.I, Gotkowski, M, Lewinski, K. Deposit date: 2019-06-05 Release date: 2019-06-19 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.1 Å) Cite: Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
6RYT	Engineered beta-lactoglobulin: variant M107L Descriptor: Beta-lactoglobulin, GLYCEROL, PHOSPHATE ION Authors: Loch, J.I, Kurpiewska, K, Lewinski, K. Deposit date: 2019-06-11 Release date: 2019-06-26 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.1 Å) Cite: Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
6E5S	Crystal structure of holo retinal-bound domain-swapped dimer Q108K:T51D mutant of human Cellular Retinol Binding Protein II Descriptor: RETINAL, Retinol-binding protein 2 Authors: Nosrati, M, Ghanbarpour, A, Geiger, J. Deposit date: 2018-07-22 Release date: 2019-07-24 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.061 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6E5R	Crystal structure of the apo domain-swapped dimer Q108K:T51D:A28C mutant of human Cellular Retinol Binding Protein II Descriptor: ACETATE ION, GLYCEROL, Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-07-22 Release date: 2019-08-07 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.592 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6QMU	A tetrahedral boronic acid diester formed by a non-natural amino acid in the ligand pocket of an engineered lipocalin Descriptor: 3-nitrophenol, Neutrophil gelatinase-associated lipocalin Authors: Skerra, A, Eichinger, A. Deposit date: 2019-02-08 Release date: 2019-08-28 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.98 Å) Cite: A Tetrahedral Boronic Acid Diester Formed by an Unnatural Amino Acid in the Ligand Pocket of an Engineered Lipocalin. Chembiochem, 21, 2020
6S2S	Hydrogenated human myelin protein P2 at 0.86-A resolution Descriptor: CITRIC ACID, Myelin P2 protein, PALMITIC ACID, ... Authors: Laulumaa, S, Kursula, P. Deposit date: 2019-06-21 Release date: 2019-08-28 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (0.86 Å) Cite: Sub-Atomic Resolution Crystal Structures Reveal Conserved Geometric Outliers at Functional Sites. Molecules, 24, 2019
6S2M	Perdeuterated human myelin protein P2 at 0.72-A resolution Descriptor: Myelin P2 protein, PALMITIC ACID, VACCENIC ACID Authors: Laulumaa, S, Kursula, P. Deposit date: 2019-06-21 Release date: 2019-08-28 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (0.72 Å) Cite: Sub-Atomic Resolution Crystal Structures Reveal Conserved Geometric Outliers at Functional Sites. Molecules, 24, 2019
6O5D	PYOCHELIN Descriptor: GLYCEROL, Neutrophil gelatinase-associated lipocalin, SULFATE ION Authors: Rupert, P.B, Strong, R.K, Clifton, M.C, Edwards, T.E, Seattle Structural Genomics Center for Infectious Disease (SSGCID) Deposit date: 2019-03-01 Release date: 2019-09-11 Last modified: 2020-07-29 Method: X-RAY DIFFRACTION (2.4 Å) Cite: Parsing the functional specificity of Siderocalin/Lipocalin 2/NGAL for siderophores and related small-molecule ligands. J Struct Biol X, 2, 2019
6NRE	Monomeric Lipocalin Can F 6 Descriptor: Lipocalin-Can f 6 allergen Authors: Clayton G, M, Kappler J, W, Chan, S. Deposit date: 2019-01-23 Release date: 2019-09-25 Method: X-RAY DIFFRACTION (2.06 Å) Cite: Structural characteristics of lipocalin allergens: Crystal structure of the immunogenic dog allergen Can f 6. Plos One, 14, 2019
6MOW	Crystal Structure of the apo R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121Q mutant of Human Cellular Retinoic Acid Binding Protein II at 2.3 Angstrom Resolution Descriptor: Cellular retinoic acid-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-10-04 Release date: 2019-10-09 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.354 Å) Cite: Crystal Structure of the apo R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121Q mutant of Human Cellular Retinoic Acid Binding Protein II at 2.3 Angstrom Resolution To Be Published
6ON5	Crystal Structure of the Zn-bound Domain-Swapped Dimer Q108K:T51D:A28C:L36C:F57H Mutant of Human Cellular Retinol Binding Protein II Descriptor: Retinol-binding protein 2, ZINC ION Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2019-04-20 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.638 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6ON8	Crystal Structure of the Reduced Form of Apo Domain-Swapped Dimer Q108K:T51D:A28C:L36C:F57H Mutant of Human Cellular Retinol Binding Protein II Descriptor: Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2019-04-20 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.395 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6E51	Crystal structure of the apo domain-swapped dimer Q108K:K40L:T51W mutant of human cellular retinol binding protein II Descriptor: Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-07-19 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.256 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6E50	Crystal structure of the apo domain-swapped dimer Q108K:K40L:T51F mutant of human Cellular Retinol Binding Protein II Descriptor: ACETATE ION, Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2018-07-18 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.965 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019

<17181920212223242526272829303132>